Updated
Reviewed
Jun. 03, 2021

Appendix B: Drug Characteristics Tables

Characteristics of Protease Inhibitors

Appendix B, Table 5. Characteristics of Protease Inhibitors

The older protease inhibitors (PIs) fosamprenavir (FPV), indinavir (IDV), nelfinavir (NFV), saquinavir (SQV), and tipranavir (TPV) are no longer used commonly in clinical practice and have been removed from this table. Please refer to the July 10, 2019 version of the guidelines (found in the archived guidelines section of Clinicalinfo) or to the Food and Drug Administration product labels for information regarding these drugs.

Appendix B, Table 5. Characteristics of Protease Inhibitorsa
   
   
   
   

Appendix B: Drug Characteristics Tables

Characteristics of Protease Inhibitors

Appendix B, Table 5. Characteristics of Protease Inhibitors

The older protease inhibitors (PIs) fosamprenavir (FPV), indinavir (IDV), nelfinavir (NFV), saquinavir (SQV), and tipranavir (TPV) are no longer used commonly in clinical practice and have been removed from this table. Please refer to the July 10, 2019 version of the guidelines (found in the archived guidelines section of Clinicalinfo) or to the Food and Drug Administration product labels for information regarding these drugs.

Appendix B, Table 5. Characteristics of Protease Inhibitorsa
   
   
   
   

Download Guidelines